Ruimin Xu

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 2

Top Topics

Ejection Fraction

Advanced Cancer

Systematic Review

Top Venues

Current cancer drug targets

This page only lists publications with an associated author ORCID identifier.

Publications

Yi Wang, Xianling Du, Hongqiang Xin, Ruimin Xu
Efficacy and Safety of Phosphatidylinositol 3-kinase Inhibitors for Patients with Breast Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Current cancer drug targets (2024)
Yi Wang, Xianling Du, Hongqiang Xin, Ruimin Xu
Efficacy and Safety of Phosphatidylinositol 3-kinase Inhibitors for Patients with Breast Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Current cancer drug targets 24 (9) (2024)